Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Michael Clay

Concepts (316)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lipoma
4
2022
17
1.760
 Why?
Biomarkers, Tumor
10
2024
1321
1.720
 Why?
Soft Tissue Neoplasms
5
2024
131
1.180
 Why?
Proto-Oncogene Proteins c-mdm2
4
2024
67
1.170
 Why?
Liposarcoma
4
2024
31
1.060
 Why?
Rhabdomyosarcoma
4
2022
65
0.990
 Why?
Adrenal Cortex Neoplasms
3
2023
70
0.970
 Why?
In Situ Hybridization, Fluorescence
5
2024
325
0.910
 Why?
Adrenocortical Carcinoma
2
2023
72
0.840
 Why?
DNA Methylation
5
2024
674
0.830
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2013
61
0.750
 Why?
Carcinoma, Ductal, Breast
2
2013
89
0.740
 Why?
Tissue Scaffolds
1
2024
221
0.720
 Why?
Surgical Wound Infection
1
2024
329
0.670
 Why?
Immunohistochemistry
7
2024
1716
0.660
 Why?
Extracellular Matrix
1
2024
562
0.630
 Why?
Fibroma
1
2020
21
0.620
 Why?
Gene Expression Regulation, Neoplastic
5
2021
1443
0.580
 Why?
Succinate Dehydrogenase
1
2019
65
0.570
 Why?
Gastrointestinal Stromal Tumors
1
2019
41
0.570
 Why?
Gastrointestinal Neoplasms
1
2019
73
0.560
 Why?
Gene Expression Profiling
4
2025
1767
0.500
 Why?
Kidney Neoplasms
4
2024
413
0.500
 Why?
Breast Neoplasms
3
2014
2382
0.490
 Why?
Cyclin-Dependent Kinase 4
1
2016
53
0.480
 Why?
Gene Amplification
2
2020
118
0.480
 Why?
DNA Mismatch Repair
1
2014
53
0.420
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2014
41
0.410
 Why?
Neoplasms, Second Primary
1
2014
102
0.390
 Why?
Receptor, Notch1
1
2013
63
0.390
 Why?
Tumor Suppressor Protein p53
4
2023
534
0.390
 Why?
Diagnosis, Differential
6
2024
1508
0.380
 Why?
Translocation, Genetic
1
2013
119
0.380
 Why?
Microtubule-Associated Proteins
1
2013
194
0.370
 Why?
Wilms Tumor
3
2023
89
0.350
 Why?
Sexually Transmitted Diseases, Viral
1
2010
11
0.320
 Why?
Lymphangioleiomyomatosis
1
2011
37
0.320
 Why?
Myometrium
1
2011
38
0.320
 Why?
Li-Fraumeni Syndrome
2
2021
15
0.320
 Why?
Anus Neoplasms
1
2010
32
0.310
 Why?
Nuclear Proteins
4
2021
740
0.310
 Why?
Uterine Neoplasms
1
2011
98
0.310
 Why?
Humans
45
2026
145475
0.280
 Why?
Germ-Line Mutation
2
2021
176
0.280
 Why?
Male
29
2026
72843
0.250
 Why?
Genomics
3
2021
825
0.250
 Why?
Child, Preschool
11
2026
11853
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2020
1963
0.230
 Why?
Female
28
2026
78845
0.230
 Why?
Child, Hospitalized
1
2026
54
0.230
 Why?
Oncogene Proteins, Fusion
2
2024
212
0.220
 Why?
Arthritis, Juvenile
1
2025
60
0.220
 Why?
Myoepithelioma
1
2024
3
0.220
 Why?
Hyphae
1
2024
11
0.220
 Why?
Synovial Membrane
1
2025
123
0.210
 Why?
Epigenesis, Genetic
3
2024
679
0.210
 Why?
Neoplasms
4
2021
2906
0.210
 Why?
Child
17
2026
22707
0.200
 Why?
Adamantinoma
1
2023
4
0.200
 Why?
Young Adult
8
2024
14219
0.200
 Why?
Fungi
1
2024
121
0.200
 Why?
Oncogene Fusion
2
2020
11
0.200
 Why?
Adult
16
2026
40777
0.200
 Why?
Antineoplastic Agents
3
2023
2214
0.190
 Why?
Adolescent
11
2026
22530
0.190
 Why?
X-linked Nuclear Protein
2
2020
8
0.190
 Why?
Meniscus
1
2023
23
0.190
 Why?
Rhabdomyosarcoma, Embryonal
1
2022
16
0.180
 Why?
Wound Healing
1
2024
355
0.170
 Why?
Liver Neoplasms
2
2019
776
0.170
 Why?
Neuroblastoma
2
2020
174
0.170
 Why?
Infant
10
2021
10077
0.170
 Why?
Immunoglobulin A
1
2022
214
0.170
 Why?
In Situ Hybridization
1
2021
318
0.170
 Why?
Penetrance
1
2021
30
0.170
 Why?
Mutation
4
2021
4075
0.170
 Why?
Bone Neoplasms
1
2023
259
0.170
 Why?
Orthopedic Procedures
1
2023
244
0.160
 Why?
Aged, 80 and over
5
2024
8333
0.160
 Why?
Myofibroma
1
2020
3
0.160
 Why?
Germ Cells
1
2021
65
0.160
 Why?
DNA Copy Number Variations
1
2021
184
0.160
 Why?
Introns
1
2021
255
0.160
 Why?
Xanthogranuloma, Juvenile
1
2020
6
0.160
 Why?
Xenograft Model Antitumor Assays
3
2019
934
0.160
 Why?
Whole Genome Sequencing
1
2021
177
0.160
 Why?
Middle Aged
11
2024
36215
0.160
 Why?
Tandem Repeat Sequences
2
2017
23
0.160
 Why?
Anterior Cruciate Ligament Injuries
1
2023
218
0.160
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2020
31
0.160
 Why?
Exons
1
2021
363
0.160
 Why?
Neoplasm Recurrence, Local
3
2022
1149
0.160
 Why?
Sarcoma, Ewing
1
2021
103
0.160
 Why?
N-Myc Proto-Oncogene Protein
1
2020
11
0.160
 Why?
Receptor, trkA
1
2020
18
0.160
 Why?
Ubiquitin Thiolesterase
1
2020
68
0.160
 Why?
Aged
8
2024
26153
0.150
 Why?
Lamin Type A
1
2020
49
0.150
 Why?
Disease Susceptibility
1
2021
344
0.150
 Why?
Phthalazines
1
2020
63
0.150
 Why?
Computational Biology
2
2021
669
0.150
 Why?
Osteoarthritis, Knee
1
2023
280
0.150
 Why?
Cell Nucleus
2
2020
588
0.150
 Why?
Phenotype
2
2020
3155
0.150
 Why?
Clonal Evolution
1
2019
47
0.150
 Why?
Cell Dedifferentiation
1
2019
32
0.150
 Why?
Narcotics
1
2019
58
0.150
 Why?
Office Visits
1
2019
92
0.150
 Why?
Mental Health
1
2026
793
0.150
 Why?
Transcriptome
1
2025
1038
0.140
 Why?
Mutation, Missense
1
2021
335
0.140
 Why?
Muscle Neoplasms
1
2018
9
0.140
 Why?
Psychomotor Disorders
1
2018
15
0.140
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
133
0.140
 Why?
Anxiety
1
2026
1118
0.140
 Why?
DNA Damage
1
2021
437
0.140
 Why?
Scrotum
1
2018
25
0.140
 Why?
Patella
1
2018
28
0.140
 Why?
Rhabdoid Tumor
1
2019
102
0.140
 Why?
Protein-Tyrosine Kinases
2
2018
431
0.140
 Why?
Codon, Nonsense
1
2018
44
0.140
 Why?
ErbB Receptors
2
2022
635
0.140
 Why?
Neuroendocrine Tumors
1
2019
119
0.130
 Why?
Arthroplasty, Replacement, Knee
1
2023
374
0.130
 Why?
Immunophenotyping
1
2019
319
0.130
 Why?
Craniofacial Abnormalities
1
2018
78
0.130
 Why?
Histone Acetyltransferases
1
2018
57
0.130
 Why?
Health Expenditures
1
2019
194
0.130
 Why?
Tumor Burden
2
2017
325
0.130
 Why?
Urogenital Abnormalities
1
2018
71
0.130
 Why?
Prognosis
3
2022
4316
0.130
 Why?
Fused Kidney
1
2017
1
0.130
 Why?
Heterozygote
1
2018
313
0.130
 Why?
Mice
8
2022
18329
0.130
 Why?
Arthritis, Rheumatoid
2
2025
1180
0.130
 Why?
Cell Cycle Proteins
2
2018
630
0.130
 Why?
Proto-Oncogene Proteins c-bcl-6
1
2017
11
0.130
 Why?
Sarcoma, Clear Cell
1
2017
10
0.130
 Why?
Fibrosarcoma
1
2017
23
0.130
 Why?
Drug Prescriptions
1
2019
288
0.130
 Why?
Beckwith-Wiedemann Syndrome
1
2016
7
0.130
 Why?
Parents
1
2026
1403
0.130
 Why?
Opiate Substitution Treatment
1
2019
188
0.120
 Why?
Single-Cell Analysis
1
2020
362
0.120
 Why?
Insurance, Health
1
2019
310
0.120
 Why?
Hemangioendothelioma
1
2016
13
0.120
 Why?
Intellectual Disability
1
2018
179
0.120
 Why?
Kasabach-Merritt Syndrome
1
2016
8
0.120
 Why?
Ectodermal Dysplasia
1
2016
20
0.120
 Why?
Genetic Variation
1
2021
972
0.120
 Why?
Depression
1
2026
1546
0.120
 Why?
Scalp
1
2016
38
0.120
 Why?
Reproducibility of Results
2
2015
3413
0.120
 Why?
Retrospective Studies
6
2024
17291
0.120
 Why?
Troponin
1
2015
50
0.110
 Why?
Buprenorphine
1
2019
191
0.110
 Why?
Sarcoma, Kaposi
1
2016
83
0.110
 Why?
Hospitalization
1
2026
2460
0.110
 Why?
Mismatch Repair Endonuclease PMS2
1
2014
4
0.110
 Why?
MutL Protein Homolog 1
1
2014
11
0.110
 Why?
MutS Homolog 2 Protein
1
2014
12
0.110
 Why?
Clone Cells
2
2017
263
0.110
 Why?
DNA Repair Enzymes
1
2014
29
0.110
 Why?
Chromosome Aberrations
2
2017
166
0.110
 Why?
Genetic Predisposition to Disease
3
2021
2378
0.100
 Why?
Drug Resistance, Neoplasm
1
2019
881
0.100
 Why?
Adenosine Triphosphatases
1
2014
159
0.100
 Why?
Repressor Proteins
1
2017
429
0.100
 Why?
Proto-Oncogene Proteins
1
2017
624
0.100
 Why?
DNA Mutational Analysis
1
2014
407
0.100
 Why?
Predictive Value of Tests
2
2017
2121
0.100
 Why?
Breast
1
2013
156
0.090
 Why?
Proto-Oncogene Proteins B-raf
1
2014
223
0.090
 Why?
Trastuzumab
1
2013
118
0.090
 Why?
Algorithms
1
2020
1845
0.090
 Why?
Sensitivity and Specificity
1
2016
1997
0.090
 Why?
Adaptor Proteins, Signal Transducing
1
2014
425
0.090
 Why?
Stromal Cells
2
2025
121
0.090
 Why?
Disease Management
1
2015
653
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2019
992
0.080
 Why?
Mastectomy
1
2013
184
0.080
 Why?
Epithelioid Cells
1
2011
9
0.080
 Why?
Opioid-Related Disorders
1
2019
602
0.080
 Why?
Genomic Imprinting
2
2023
27
0.080
 Why?
Penile Neoplasms
1
2010
7
0.080
 Why?
Risk Factors
2
2015
10885
0.080
 Why?
Uterine Cervical Dysplasia
1
2010
27
0.080
 Why?
Kidney
1
2018
1497
0.080
 Why?
Disease Models, Animal
1
2021
4560
0.080
 Why?
Animals
10
2023
38030
0.080
 Why?
DNA, Neoplasm
1
2010
158
0.080
 Why?
Brain Neoplasms
1
2019
1329
0.080
 Why?
Papillomaviridae
1
2010
116
0.080
 Why?
Combined Modality Therapy
1
2013
1266
0.080
 Why?
Critical Illness
1
2015
900
0.070
 Why?
Mice, Nude
2
2021
679
0.070
 Why?
Neoplasm Staging
1
2013
1471
0.070
 Why?
Sequence Analysis, RNA
2
2021
442
0.070
 Why?
Prospective Studies
2
2026
8057
0.070
 Why?
Liver
1
2016
1896
0.070
 Why?
Fibroblasts
2
2025
1025
0.070
 Why?
Tomography, X-Ray Computed
1
2018
2769
0.070
 Why?
DNA-Binding Proteins
1
2014
1480
0.060
 Why?
Uterine Cervical Neoplasms
1
2010
268
0.060
 Why?
Databases, Factual
1
2013
1490
0.060
 Why?
DNA
2
2023
1435
0.060
 Why?
Receptor, Notch3
1
2025
8
0.060
 Why?
Chemokine CXCL13
1
2025
15
0.060
 Why?
Receptors, CXCR3
1
2025
17
0.060
 Why?
Receptors, CXCR5
1
2025
27
0.060
 Why?
Rodent Control
1
1985
2
0.060
 Why?
Leptospira interrogans
1
1985
4
0.060
 Why?
Chemokine CXCL9
1
2025
38
0.060
 Why?
Leptospirosis
1
1985
8
0.060
 Why?
Chemokine CXCL12
1
2025
86
0.060
 Why?
Carcinoma, Squamous Cell
1
2010
641
0.060
 Why?
Signal Transduction
3
2025
5216
0.050
 Why?
Gene Fusion
1
2024
30
0.050
 Why?
Diaphyses
1
2023
10
0.050
 Why?
Ulna
1
2023
35
0.050
 Why?
Occupational Diseases
1
1985
165
0.050
 Why?
Activating Transcription Factor 4
1
2023
22
0.050
 Why?
Fibula
1
2023
36
0.050
 Why?
Proteasome Inhibitors
1
2023
41
0.050
 Why?
Adenocarcinoma
1
2010
925
0.050
 Why?
Proteasome Endopeptidase Complex
1
2023
155
0.050
 Why?
Imidazoles
1
2023
247
0.040
 Why?
Drug Resistance
1
2022
145
0.040
 Why?
Carcinoma, Renal Cell
1
2024
230
0.040
 Why?
Muscle Development
1
2022
112
0.040
 Why?
Gene Knock-In Techniques
1
2021
61
0.040
 Why?
Myositis Ossificans
1
2020
4
0.040
 Why?
Periosteum
1
2020
14
0.040
 Why?
Fasciitis
1
2020
11
0.040
 Why?
Cellular Senescence
1
2023
226
0.040
 Why?
Piperazines
1
2023
375
0.040
 Why?
Brazil
1
2021
179
0.040
 Why?
Biopsy
1
2024
1082
0.040
 Why?
Dasatinib
1
2020
58
0.040
 Why?
Freezing
1
2020
83
0.040
 Why?
Complement Activation
1
2023
399
0.040
 Why?
Autoantigens
1
2022
427
0.040
 Why?
Gene Rearrangement
1
2020
155
0.040
 Why?
CD8-Positive T-Lymphocytes
1
2025
919
0.040
 Why?
Etoposide
1
2019
168
0.040
 Why?
Carboplatin
1
2019
162
0.040
 Why?
Receptors, Immunologic
1
2020
208
0.040
 Why?
Mice, SCID
1
2019
369
0.040
 Why?
Organophosphorus Compounds
1
2019
84
0.040
 Why?
Prevalence
1
2026
2865
0.040
 Why?
Neoplasm Grading
1
2019
310
0.040
 Why?
Genotype
1
2023
1852
0.040
 Why?
Tumor Microenvironment
1
2023
734
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
44
0.040
 Why?
Tumor Cells, Cultured
1
2020
886
0.030
 Why?
Unfolded Protein Response
1
2018
58
0.030
 Why?
Longitudinal Studies
1
2026
2953
0.030
 Why?
Immunoglobulin G
1
2022
892
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p57
1
2017
5
0.030
 Why?
Epigenomics
1
2018
114
0.030
 Why?
Macrophages
1
2025
1507
0.030
 Why?
Chromosomes, Human, Pair 11
1
2017
59
0.030
 Why?
Genes, p53
1
2017
67
0.030
 Why?
Bortezomib
1
2017
54
0.030
 Why?
Membrane Glycoproteins
1
2020
499
0.030
 Why?
Infant, Newborn
2
2021
6447
0.030
 Why?
Hydroxamic Acids
1
2017
94
0.030
 Why?
Cohort Studies
2
2020
6013
0.030
 Why?
Heterografts
1
2017
143
0.030
 Why?
Reactive Oxygen Species
1
2020
611
0.030
 Why?
Vincristine
1
2017
142
0.030
 Why?
Camptothecin
1
2017
138
0.030
 Why?
Pyrimidinones
1
2017
125
0.030
 Why?
Mice, Transgenic
1
2021
2188
0.030
 Why?
Family
1
2020
682
0.030
 Why?
High-Throughput Screening Assays
1
2017
176
0.030
 Why?
beta Catenin
1
2017
254
0.030
 Why?
Molecular Targeted Therapy
1
2018
439
0.030
 Why?
Antibodies, Monoclonal
1
2022
1505
0.030
 Why?
Medicaid
1
2019
467
0.030
 Why?
Autoantibodies
1
2022
1509
0.030
 Why?
Apoptosis
1
2023
2440
0.030
 Why?
Drug Therapy, Combination
1
2017
1044
0.030
 Why?
Leukocyte Transfusion
1
1994
5
0.030
 Why?
Precision Medicine
1
2018
459
0.030
 Why?
Granulocytes
1
1994
81
0.030
 Why?
Polymerase Chain Reaction
1
2017
1041
0.030
 Why?
Pyrimidines
1
2017
530
0.020
 Why?
Medicare
1
2019
903
0.020
 Why?
Indoles
1
2017
507
0.020
 Why?
Pyrazoles
1
2017
517
0.020
 Why?
Cells, Cultured
1
2021
4148
0.020
 Why?
Mycoses
1
1994
88
0.020
 Why?
Neutropenia
1
1994
154
0.020
 Why?
Mitochondria
1
2020
992
0.020
 Why?
Mice, Knockout
1
2020
3124
0.020
 Why?
Bone Marrow Transplantation
1
1994
298
0.020
 Why?
Healthcare Disparities
1
2019
735
0.020
 Why?
Aging
1
2023
1969
0.020
 Why?
Acute Coronary Syndrome
1
2015
297
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2015
443
0.020
 Why?
Proteomics
1
2018
1188
0.020
 Why?
United States Department of Veterans Affairs
1
2015
778
0.020
 Why?
Hospital Mortality
1
2015
1038
0.020
 Why?
Cell Line, Tumor
1
2018
3542
0.020
 Why?
United States
2
2019
16098
0.020
 Why?
Mice, Inbred C57BL
1
2021
5983
0.020
 Why?
Registries
1
2017
2406
0.020
 Why?
Epidemiologic Methods
1
1985
91
0.010
 Why?
Michigan
1
1985
134
0.010
 Why?
Treatment Outcome
1
2019
11772
0.010
 Why?
Biomarkers
1
2015
4295
0.010
 Why?
Rats
1
1985
5584
0.010
 Why?
Aspergillus
1
1994
18
0.010
 Why?
Candidiasis
1
1994
64
0.010
 Why?
Candida albicans
1
1994
61
0.010
 Why?
Clay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (316) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)